References of "Gast, Pierrette"
     in
Bookmark and Share    
Full Text
See detailThe thyrogastric syndrome : an under diagnosed etiology for acquired gastric neuroendocrine tumors. A case report
VALDES SOCIN, Hernan Gonzalo ULg; LOLY, Jean ULg; GAST, Pierrette ULg et al

in Abstract Book - 13th International Workshop on Multiple Endocrine Neoplasia (2012, September)

Detailed reference viewed: 42 (10 ULg)
Full Text
Peer Reviewed
See detailCommentary: endoscopic dilatation for stricturing Crohn's disease.
Louis, Edouard ULg; GAST, Pierrette ULg; VAN KEMSEKE, Catherine ULg et al

in Alimentary Pharmacology & Therapeutics (2012), 36(5), 494-6

Detailed reference viewed: 5 (1 ULg)
Full Text
See detailL'oesophagite à éosinophiles chez l'adulte : à propos d'un cas
Marting, Audrey ULg; Leclercq, Philippe ULg; Gast, Pierrette ULg et al

in Revue Médicale de Liège (2008), 63

Detailed reference viewed: 204 (6 ULg)
Full Text
Peer Reviewed
See detaileosinophilic esophagitis
Leclercq, Philippe ULg; Marting, Audrey; Gast, Pierrette ULg

in New England Journal of Medicine [=NEJM] (2007), 357(14),

Detailed reference viewed: 23 (2 ULg)
Full Text
Peer Reviewed
See detailAlcoholisation of a hepatocarcinoma guided by echoendoscopy
Gast, Pierrette ULg; Delwaide, Jean ULg; Gillard, Vincent ULg et al

in Acta Endoscopica (2006), 36(1), 74

Detailed reference viewed: 21 (2 ULg)
Peer Reviewed
See detailRecommandations en matiere de traitement du cancer rectal
Gast, Pierrette ULg; Bours, Vincent ULg; Detroz, Bernard ULg et al

in Revue Médicale de Liège (2000), 55(5), 350-5

Curative resection of primary tumor and metastases is the only way to obtain a prolonged survival. Several additional treatments are under evaluation; some are already routinely proposed, in order to ... [more ▼]

Curative resection of primary tumor and metastases is the only way to obtain a prolonged survival. Several additional treatments are under evaluation; some are already routinely proposed, in order to reduce the tumor size and to allow surgery, to reduce the recurrence rate, and to give a better survival in case of unresectable metastases. Even in case of unresectable metastases, resection of the primary tumor should be envisaged, as quality of life with an evolving rectal tumor is very poor. [less ▲]

Detailed reference viewed: 22 (4 ULg)
Full Text
Peer Reviewed
See detailClinical biliary complications after adult liver transplantation: a prospective study
Detry, Olivier ULg; Maweja, Sylvie ULg; Delwaide, Jean ULg et al

in Acta Gastro-Enterologica Belgica (2000, March), 63(1), 56

Detailed reference viewed: 18 (5 ULg)
Peer Reviewed
See detailPharma clinics. Comment je préviens et je traite ... les ulcères de stress
Fraipont, V.; Lambermont, Bernard ULg; Gast, Pierrette ULg et al

in Revue Médicale de Liège (1998), 53(8), 444-9

Stress related ulcers are superficial and extensive gastric mucosal lesions. They occur in almost all critically ill patients but lead to gastrointestinal bleedings in only 5 to 10%. Endoscopy permits ... [more ▼]

Stress related ulcers are superficial and extensive gastric mucosal lesions. They occur in almost all critically ill patients but lead to gastrointestinal bleedings in only 5 to 10%. Endoscopy permits definitive diagnostic. Stress related mucosal diseases encount for substantial morbidity and mortality. The preventive therapeutic choice depends on efficacy, side effects as cost and nosocomial pneumonia. Sulcralfate appears to be the best choice because of its lower cost, comparable efficacy (sucralfate versus anti-H2) and its lower risk of inducing nosocomial pneumonia. Patients who greatly benefit from prevention, present respiratory failure with at least 48 hours mechanical ventilation, coagulopathy, sepsis or burns. Global management avoiding hypoxia, hypotension and acidosis, takes an important part in the prevention. [less ▲]

Detailed reference viewed: 29 (1 ULg)
Peer Reviewed
See detailComment je préviens et je traite : les ulcères de stress
FRAIPONT, V; LAMBERMONT, Bernard ULg; GAST, Pierrette ULg et al

in Revue Médicale de Liège (1998), 53

Detailed reference viewed: 1 (0 ULg)
Peer Reviewed
See detailEffects of Proglumide and Enprostil on Omeprazole-Induced Fundic Endocrine Cell Hyperplasia in Rats
Delwaide, Jean ULg; Latour, Pascale ULg; Gast, Pierrette ULg et al

in Gastroentérologie Clinique et Biologique (1993), 17(11), 792-6

Long-term treatment with omeprazole induces hyperplasia of enterochromaffin-like cells, closely related to hypergastrinemia. We studied whether proglumide, an antagonist of gastrin/CCK receptor, and ... [more ▼]

Long-term treatment with omeprazole induces hyperplasia of enterochromaffin-like cells, closely related to hypergastrinemia. We studied whether proglumide, an antagonist of gastrin/CCK receptor, and enprostil, a synthetic prostaglandin E2 derivative, might inhibit this hyperplasia. Six groups of 8 rats were treated for 10 weeks: a) untreated controls; b) omeprazole 10 mumol/kg; c) proglumide 500 mg/kg; d) enprostil 30 micrograms/kg; e) association of omeprazole and proglumide; f) association of omeprazole and enprostil. Serum gastrin levels were measured at different times during treatment. After sacrifice, fundic argyrophil cells were assessed by Grimelius' staining. Serum gastrin levels and argyrophil cell density were not modified in proglumide- and enprostil-treated groups, as compared with controls. Omeprazole increased significantly these two parameters. When given with omeprazole, proglumide decreased significantly serum gastrin levels and argyrophil cell density, as compared to omeprazole alone, while enprostil did not modify significantly these two parameters. These results indicate that proglumide, but not enprostil, can counteract the omeprazole-induced argyrophil cell hyperplasia in rats. [less ▲]

Detailed reference viewed: 25 (2 ULg)
Peer Reviewed
See detailFundic Argyrophil Cell Hyperplasia in Atrophic Gastritis: A Search for a Sensitive Diagnostic Method
Belaiche, Jacques ULg; Delwaide, Jean ULg; Vivario, M. et al

in Acta Gastro-Enterologica Belgica (1993), 56(1, Jan-Feb), 11-7

Hypergastrinemia induces argyrophil cell hyperplasia in oxyntic mucosa (FACH) in patients with non-antral atrophic gastritis, with or without pernicious anemia. This proliferation favours the development ... [more ▼]

Hypergastrinemia induces argyrophil cell hyperplasia in oxyntic mucosa (FACH) in patients with non-antral atrophic gastritis, with or without pernicious anemia. This proliferation favours the development of carcinoid tumours. In order to determine the most usual appropriate method to document FACH, we have studied 29 consecutive fundic biopsies from 26 patients with fundic chronic gastritis. The study encompassed gastrinemia levels, standard histology permitting the classification of chronic gastritis, demonstration of FACH by Grimelius stain, immunohistochemical studies using NSE, chromogranin A and by electron microscopy. The FACH was classified for each stain as slight, moderate or severe. The study displayed a relationship between the grade of gastritis and the density of argyrophil endocrine cells in oxyntic mucosa assessed by Grimelius stain (p < 0.0001) and chromogranin A (P < 0.01). There was also a relationship between the serum gastrin level and the density of argyrophil endocrine cells detected by these two stains (p < 0.001). A highly significant correlation was observed between Grimelius stain and chromogranin A (p < 0.0001). On the other hand, no significant correlation was noted with either NSE or electron microscopy. We conclude that Grimelius stain and immunohistochemical studies against chromogranin A were the best methods for the demonstration of FACH in atrophic gastritis. One of these two techniques is sufficient in current practice for defining the patients at risk for subsequent surveillance. [less ▲]

Detailed reference viewed: 56 (6 ULg)
Full Text
Peer Reviewed
See detailApports récents de la génétique dans les maladies inflammatoires intestinales
Louis, Edouard ULg; Belaiche, Jacques ULg; Franchimont, D. et al

in Acta Clinica Belgica (1993), 48(6), 383-91

It is clear since many years that the liability to develop inflammatory bowel disease is influenced by genetic factors. Recent progresses in the field of genetic markers and genetic models bring the ... [more ▼]

It is clear since many years that the liability to develop inflammatory bowel disease is influenced by genetic factors. Recent progresses in the field of genetic markers and genetic models bring the concept of genetic heterogeneity. This new concept leads us to try to classify different forms of inflammatory bowel disease and could have in the future an impact on the prevention, the follow up and the treatment of these diseases. [less ▲]

Detailed reference viewed: 26 (5 ULg)
Peer Reviewed
See detailLes cellules ECL et leurs récepteurs: rôle physiologique et intérêt physiopathologique
Belaiche, Jacques ULg; Delwaide, Jean ULg; Louis, Edouard ULg et al

in Acta Gastro-Enterologica Belgica (1993), 56(3-4, May-Aug), 235-44

The enterochromaffin-like (ECL) cells represent the predominating endocrine cell population in the oxyntic mucosa of the stomach. They are under the influence of gastrin. Recently, a histamine production ... [more ▼]

The enterochromaffin-like (ECL) cells represent the predominating endocrine cell population in the oxyntic mucosa of the stomach. They are under the influence of gastrin. Recently, a histamine production was shown within the secretory granules of ECL cells. ECL cells appear to play a crucial role in the physiology of gastric acid secretion. There are many unknowns concerning the intervention of other trophic factors in addition to gastrin and concerning the receptors located on the cells. ECL cell hyperplasia is a well documented consequence of hypergastrinemia. The latter can result from a gastrinoma or from a reduction of gastric acid secretion related to pernicious anemia or to long-term treatment with antisecretory drugs. [less ▲]

Detailed reference viewed: 32 (3 ULg)
See detailLes cellules enterochromaffin-like (ECL) : de la physiologie à la pathologie
Belaiche, Jacques ULg; Delwaide, Jean ULg; Louis, Edouard ULg et al

in Médecine et Hygiène (1992), 50

Detailed reference viewed: 17 (2 ULg)
Peer Reviewed
See detailTraitement immunosuppresseur et maladie de Crohn
Delwaide, Jean ULg; Louis, Edouard ULg; Gast, Pierrette ULg et al

in Revue Médicale de Liège (1991), 46(1), 22-8

Detailed reference viewed: 43 (1 ULg)
Peer Reviewed
See detailAspects immunologiques actuels de la maladie de Crohn
Louis, Edouard ULg; Belaiche, Jacques ULg; Gast, Pierrette ULg et al

in Revue Médicale de Liège (1991), 46(1), 2-11

Detailed reference viewed: 24 (5 ULg)
Peer Reviewed
See detailLes indices d'activité dans la maladie de Crohn
Belaiche, Jacques ULg; Louis, Edouard ULg; Delwaide, Jean ULg et al

in Revue Médicale de Liège (1991), 46(1), 11-5

Detailed reference viewed: 21 (2 ULg)
Peer Reviewed
See detailLes nouveaux dérivés de la salazosulfapyridine dans le traitement de la maladie de Crohn
Belaiche, Jacques ULg; Delwaide, Jean ULg; Louis, Edouard ULg et al

in Revue Médicale de Liège (1991), 46(1), 16-22

Detailed reference viewed: 52 (1 ULg)
Peer Reviewed
See detailUltrastructural demonstration of histamine in human enterochromaffin like cell granules.
Delwaide, Jean ULg; Vivario, M.; Belaiche, Jacques ULg et al

in Gut (1991), 32(7), 834

Detailed reference viewed: 19 (7 ULg)